FDA Inspection
Ophtapharm AGOphtapharm AG – FDA Inspection, Dec 12, 2017
Record Details
This FDA Inspection record concerns Ophtapharm AG, with an inspection on December 12, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · af1221b4-46e5-4a05-a6ae-042a56390d1f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1034597
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 211.67(b)(3)Cleaning SOPs/instructions
- 21 CFR 211.42(c)(10)Aseptic Processing Area
- 21 CFR 211.165(e)Test methods
- 21 CFR 211.166(a)Written program not followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Ophtapharm AG
5| Date | Classification | Office | Project area |
|---|---|---|---|
| July 7, 2023 | Not classified | Office of Inspections and Investigations | |
| February 28, 2020 | VAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| May 25, 2016 | VAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| March 28, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 9, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Ophtapharm AG
- FDA Inspection 1245095 - 2023-07-07
- FDA Inspection 1119623 - 2020-02-28
- FDA Inspection 980040 - 2016-05-25
- FDA Inspection 878584 - 2014-03-28
- FDA Inspection 754443 - 2011-11-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.